| Hazer Group Limited (HZR) ORDINARY FULLY PAID |
Materials |
$87 |
Corporate Presentation
|
29 Jul 2026 8:35AM |
$0.320 |
$0.325 |
risen by
1.56%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$11 |
Change of Director's Interest Notice - PV
|
29 Jul 2026 8:34AM |
$0.065 |
$0.060 |
fallen by
7.69%
|
|
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$49 |
Quarterly Activities Report and Appendix 4C - 30 Jun 26
|
29 Jul 2026 8:34AM |
$0.062 |
$0.065 |
risen by
4.84%
|
|
XRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash receipts for Q4 totaled $6.9 million, a 46% increase from the previous corresponding period.
- Net operating cashflow for Q4 was $2.2 million, showing a 64% increase from the previous corresponding period.
- The annual recurring revenue reached $8.0 million, increasing by 69%.
- Total contract value for FY26 was $13.0 million, a 27% increase quarter-over-quarter.
- The U.S. Department of Defense project worth $5.6 million was completed on time and on budget.
- A memorandum of understanding was signed with Thales Australia to explore opportunities in defense, security, and law enforcement training.
- First European contract was secured with the Swedish Armed Forces valued at approximately $0.45 million.
- Debt reduction efforts saw $0.8 million repaid, leaving a $4.65 million balance on the Causeway facility.
- Operator XR's customer base grew by 13% quarter-over-quarter to 118 customers worldwide.
- The company focused on transitioning towards a scalable software business model.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IRIS Metals Limited (IR1) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2026 8:34AM |
$0.060 |
$0.050 |
fallen by
16.67%
|
|
IR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for period ending 30 June 2026 released.
- Highlights include ongoing projects in Finley Basin and Beecher.
- Cash balance decreased from $4.6 million to $3.1 million.
- No cash flows from financing activities reported.
- Exploration and evaluation costs were $0.6 million.
- Staff and administration costs totaled $0.7 million.
- Company plans to rename to Palisade Metals Limited.
- Head office relocating from Melbourne to Perth.
- Future drilling programs planned for exploration sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Many Peaks Minerals Limited (MPK) ORDINARY FULLY PAID |
Materials |
$138 |
Quarterly Activities Report & Appendix 5B
|
29 Jul 2026 8:34AM |
$0.805 |
$0.830 |
risen by
3.11%
|
|
MPK - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden Mineral Resource Estimate completed for the Ouarigue prospect of 26.7Mt @ 1.54g/t Au for 1.32Moz of contained gold.
- Ongoing drilling expanded confidence in gold mineralisation at Ouarigue with significant results from diamond and reverse circulation drilling.
- Ferké Gold Project remains the flagship project in Côte d’Ivoire, with multiple drilling activities underway.
- Pre-Feasibility Study activities at Ferké are progressing, targeting completion by the December Quarter.
- Odienné Gold Project saw successful completion of geophysical surveys and expanded air core drilling program.
- Baga Gold Project identified multiple targets for follow-up exploration.
- The company completed a A$27.5M equity placement and has A$26.7M cash and investments as of 30 June 2026.
- Many Peaks retains options to acquire interests in several projects, holding significant stakes in Côte d'Ivoire permits through joint ventures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$6,763 |
June 2026 Quarterly Report conference call presentation
|
29 Jul 2026 8:33AM |
$3.080 |
$3.580 |
risen by
16.23%
|
|
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$22 |
Quarterly Report - Q4 FY26
|
29 Jul 2026 8:33AM |
$0.270 |
$0.240 |
fallen by
11.11%
|
|
NXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant advance in Asia-Pacific strategy.
- Partnership with Gleneagles Hospital Hong Kong.
- Appointment of Dr. Kenneth Tsang to Advisory Board.
- Launch of Malaysian research facility with Universiti Malaya.
- Ended quarter with $4.49 million in cash reserves.
- Consistent expenditure with IPO Prospectus, with some accelerations.
- More than $1.5 million in additional non-dilutive funding secured.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$899 |
Update - Notification of buy-back - FPR
|
29 Jul 2026 8:32AM |
$2.840 |
$4.210 |
risen by
48.24%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$11 |
Change of Director's Interest Notice - PD
|
29 Jul 2026 8:32AM |
$0.065 |
$0.060 |
fallen by
7.69%
|
|
| FMR Resources Limited (FMR) ORDINARY FULLY PAID |
Communication Services |
$25 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2026 8:32AM |
$0.418 |
$0.395 |
fallen by
5.39%
|
|
FMR - Price-sensitive ASX Announcement
Full Release
Key Points
- The document is FMR Resources Limited's June 2026 Quarterly Activities Report, dated 29 July 2026.
- The report includes results from surface rock chip samples at the La Martuca and Esperanza Prospects, with variable copper and gold tenor due to multiple mineralisation events.
- High-grade copper mineralisation at La Martuca is associated with quartz sulphide vein systems, while gold values at Esperanza are linked to epithermal quartz veining.
- FMR Resources Limited has a 5-year option to purchase concessions hosting the La Martuca and Esperanza Prospects.
- The company conducted exploration activities with significant expenditures and no substantive mining production in the quarter.
- Appendix 5B provides a detailed cash flow report indicating net cash flows from operating, investing, and financing activities.
- The company engaged in financing activities raising $3,698,000 in the current quarter and $7,960,000 year to date.
- There were no tenements acquired or disposed of during the quarter.
- Payments to related parties were detailed, aligning with ASX listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saluda Medical, Inc. (SLD) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$158 |
Quarterly Investor Presentation
|
29 Jul 2026 8:31AM |
$0.410 |
$0.625 |
risen by
52.44%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$65 |
New US Lung Imaging Guidelines Name Technegas as Preferred A
|
29 Jul 2026 8:31AM |
$0.520 |
$0.515 |
fallen by
0.96%
|
|
CYC - Price-sensitive ASX Announcement
Full Release
Key Points
- Technegas® named as the preferred ventilation agent in new US lung imaging guidelines.
- New guidelines published by four international nuclear medicine societies.
- The guidelines endorse three-dimensional imaging techniques beneficial for Technegas®.
- Technegas® offers a lower radiation dose compared to CT pulmonary angiogram.
- Guidelines expand the use of Technegas® beyond pulmonary embolism diagnosis.
- Cyclopharm sees potential for increased adoption of Technegas® in US hospitals.
- Technegas® data supports artificial intelligence applications in lung imaging.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saluda Medical, Inc. (SLD) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$158 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2026 8:31AM |
$0.410 |
$0.625 |
risen by
52.44%
|
|
SLD - Price-sensitive ASX Announcement
Full Release
Key Points
- Saluda Medical exceeded FY26 revenue guidance, achieving US$90.2 million, a 28% year-over-year growth.
- Q4 FY26 global revenue reached US$27.0 million, marking a 43% increase compared to the previous corresponding period.
- FDA approved the CAP24™ paddle lead, expanding the Evoke® System portfolio for Saluda Medical.
- US revenues increased by 45% in Q4, with a 50% rise in implanted patients and substantial growth in physician engagement.
- International revenues grew by 39% driven by strong demand in Europe and Australia.
- Saluda expanded its US sales force to 161 representatives, exceeding their target for FY26.
- The company executed a phased reduction in force to optimize future operating expenses.
- Saluda ended Q4 FY26 with US$116.4 million in cash and available funding of US$141.4 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$167 |
Quarterly Activities and Cashflow Report Jun 2026
|
29 Jul 2026 8:31AM |
$0.240 |
$0.200 |
fallen by
16.67%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated Mineral Resource Estimate shows 20% increase in tonnage.
- Significant enhancements in copper and gold content.
- New zones of copper mineralisation identified at West Mwombezhi.
- Focus on by-product potential of gold at Nyungu Central.
- High-quality copper concentrates from Kabikupa metallurgical testwork.
- Evaluation of gold and cobalt recovery continues.
- Cash balance of A$36.6 million at quarter-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$381 |
Notification of cessation of securities - PE1
|
29 Jul 2026 8:31AM |
$1.465 |
$1.430 |
fallen by
2.39%
|
|
| wrkr Ltd (WRK) ORDINARY FULLY PAID |
Information Technology |
$167 |
Share Purchase Plan Offer Booklet
|
29 Jul 2026 8:30AM |
$0.077 |
$0.079 |
risen by
3.27%
|
|
| Alkane Resources Ltd (ALK) ORDINARY FULLY PAID |
Materials |
$2,097 |
Alkane Significantly Increases Storheden Mineral Resource
|
29 Jul 2026 8:30AM |
$1.305 |
$1.535 |
risen by
17.62%
|
|
ALK - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant increase in Storheden Mineral Resource by Alkane Resources Ltd.
- Exploration update includes 16 extensional diamond drill holes.
- Gold-bearing Quartz veins delineated over 2.7 km and 464m depth.
- Mineralization remains open in all directions.
- Indicated Resources: 1.07 Mt at 2.51 g/t Au.
- Inferred Resources: 1.85 Mt at 2.11 g/t Au.
- Details to be included in annual technical report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$399 |
Quarterly Activites Report
|
29 Jul 2026 8:30AM |
$0.225 |
$0.225 |
fallen by
0%
|
|
HZN - Price-sensitive ASX Announcement
Full Release
Key Points
- Record FY26 production and sales volumes
- Gross oil production averaged 6,724 bopd in Q4
- Net oil sales and revenue: 153,105 bbls and US$17.7 million
- Cash reserves of US$37.4 million as of June 2026
- Acquisition of Cue Energy Resources Limited completed
- Expanded operations across five countries and nine fields
- Increased combined production by 15% to 7,300 boepd
- Thailand operations contributed significantly to cash flow
- Development projects progressed across portfolio
- Maintained strong balance sheet and financial discipline
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,151 |
Q2 2026 Toll Revenue & Traffic Update & New Debt Facility
|
29 Jul 2026 8:30AM |
$5.070 |
$4.920 |
fallen by
2.96%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Proportionate toll revenue for Q2 2026 decreased by 0.3% excluding foreign exchange impacts.
- Reported toll revenue was 8.1% lower due to foreign exchange movements.
- Higher fuel prices impacted light vehicle traffic in France.
- Traffic growth was positive in the US and Germany.
- APRR Group traffic decreased by 3.9% due to higher fuel prices.
- Atlas Arteria established a new A$150 million corporate term loan facility.
- The new debt facility will fund strategic financial commitments and replenish cash reserves.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$79 |
Pacific Infrastructure Position Strengthened with A$1.2m Win
|
29 Jul 2026 8:30AM |
$0.130 |
$0.215 |
risen by
65.38%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- DXN Limited secures a contract with SISCC valued at approximately A$1.2 million.
- The contract involves the design, manufacture, delivery, installation, and commissioning of a Cable Landing Station.
- The project is part of the Australian Government's ACS-1 submarine cable program.
- This initiative aims to enhance connectivity in the Solomon Islands and strengthen Pacific infrastructure.
- The project's completion is scheduled for April 2027.
- DXN emphasizes its growing credibility as a partner for significant government-backed projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$381 |
Application for quotation of securities - PE1
|
29 Jul 2026 8:30AM |
$1.465 |
$1.430 |
fallen by
2.39%
|
|
| Regener8 Resources NL (R8R) ORDINARY FULLY PAID |
Materials |
$9 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2026 8:30AM |
$0.125 |
$0.120 |
fallen by
4%
|
|
R8R - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of acquisition of Srebrenica North Project in Bosnia and Herzegovina.
- Phase 1 soil sampling completed, targeting Zanik and Chaush prospects.
- Successful completion of pro-rata entitlement offer raising $1,415,158.
- Leadership transition with recruitment of new Managing Director.
- Expenditure on exploration and evaluation during the quarter was $75,000.
- Registered office and principal location changed to 9 Aldous Place, Booragoon WA 6154.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,951 |
Net Tangible Asset Backing
|
29 Jul 2026 8:29AM |
$4.500 |
$4.650 |
risen by
3.33%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$74 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2026 8:29AM |
$0.130 |
$0.145 |
risen by
11.54%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Mature ACCENT trial data presented at AACR meeting showing positive results for narmafotinib in pancreatic cancer.
- Initiation of Phase 2b study on narmafotinib in combination with gemcitabine and Abraxane® for pancreatic cancer.
- Partnership with ANZGOG for PRROSE trial in ovarian cancer.
- Board leadership transition with Ms Jane Bell AM appointed Chair.
- New patent application filed for novel FAK inhibitors.
- Quarter ended with a cash position of A$24 million.
- Net operating cash outflows of A$3.9 million for the quarter.
- No proceeds from financing activities in the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| D3 Energy Limited (D3E) ORDINARY FULLY PAID |
Energy |
$53 |
Quarterly Activities Report and Appendix 5B - Jun 2026
|
29 Jul 2026 8:29AM |
$0.350 |
$0.350 |
fallen by
0%
|
|
D3E - Price-sensitive ASX Announcement
Full Release
Key Points
- D3 Energy commenced drilling at Nooitgedacht within the ER315 permit area in South Africa.
- Maiden Contingent and Prospective Resource certified at ER386 increased helium resources by 65% (2C) and 94% (2U).
- The Production Right Application over PR016 is under assessment, expected completion in Q4 CY2026/Q1 CY2027.
- D3 Energy holds 478,699 acres in the Free State Province, South Africa, and 5,865 km² in the Arckaringa Basin, Australia.
- ER315, PR016, and ER386 contain significant reserves and resources, enhancing D3 Energy's global position.
- Financial activities include a net cash decrement from operating activities and a cash balance of $6,742,000 at quarter-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
